PMID: 11927210Apr 3, 2002Paper

Citation bias of hepato-biliary randomized clinical trials

Journal of Clinical Epidemiology
Lise L Kjaergard, Christian Gluud

Abstract

The objective of this study was to assess whether trials with a positive (i.e., statistically significant) outcome are cited more often than negative trials. We reviewed 530 randomized clinical trials on hepato-biliary diseases published in 11 English-language journals indexed in MEDLINE from 1985-1996. From each trial, we extracted the statistical significance of the primary study outcome (positive or negative), the disease area, and methodological quality (randomization and double blinding). The number of citations during two calendar years after publication was obtained from Science Citation Index. There was a significant positive association between a statistically significant study outcome and the citation frequency (beta, 0.55, 95% confidence interval, 0.39-0.72). The disease area and adequate generation of the allocation sequence were also significant predictors of the citation frequency. We concluded that positive trials are cited significantly more often than negative trials. The association was not explained by disease area or methodological quality.

References

Apr 13, 1991·Lancet·P J EasterbrookD R Matthews
Oct 24, 1987·British Medical Journal·K Dickersin
May 1, 1995·Journal of Clinical Epidemiology·U Ravnskov
Feb 1, 1995·JAMA : the Journal of the American Medical Association·K F SchulzD G Altman
Feb 15, 1997·BMJ : British Medical Journal·P O Seglen
Jul 1, 1997·Annals of Internal Medicine·L A Bero, A R Jadad
Oct 6, 1997·BMJ : British Medical Journal·I Roberts
Feb 6, 1998·BMJ : British Medical Journal·M Egger, G D Smith
May 5, 1998·Journal of Hepatology·C Gluud
Jun 3, 1998·São Paulo Medical Journal = Revista Paulista De Medicina·A N Atallah
Aug 29, 1998·Journal of Hepatology·C Gluud, D Nikolova
Feb 3, 1999·Liver·C Gluud
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·L L KjaergardC Gluud
Nov 27, 1999·BMJ : British Medical Journal·M Clarke, A Oxman
Dec 11, 1999·BMJ : British Medical Journal·A Tonks

❮ Previous
Next ❯

Citations

Feb 28, 2006·Science and Engineering Ethics·Nicholas H Steneck
Jan 15, 2014·Lancet·Paul GlasziouElizabeth Wager
Jan 30, 2008·Nature Clinical Practice. Rheumatology·Axel Finckh, Martin R Tramèr
Jan 25, 2012·Journal of Veterinary Internal Medicine·M A Giuffrida, D C Brown
Jul 21, 2006·BMJ : British Medical Journal·Peter C Gøtzsche
Jul 15, 2004·Journal of Epidemiology and Community Health·Miguel Delgado-Rodríguez, Javier Llorca
Apr 15, 2010·Trials·Natalie McGauranThomas Kaiser
Sep 8, 2011·International Journal of Medical Sciences·Antonis ValachisEvangelos G Papanikolau
Feb 19, 2016·International Journal of Epidemiology·Ludovic TrinquartSandro Galea
Sep 10, 2013·The Spine Journal : Official Journal of the North American Spine Society·Nicholas S AndradeViktor Bartanusz
May 28, 2015·Clinical Orthopaedics and Related Research·Tommy P MrozGiles R Scuderi
Jan 9, 2009·Journal of Clinical Epidemiology·Jean-François Etter, John Stapleton
Jun 28, 2008·Seminars in Hematology·John P A Ioannidis
Jul 17, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·John P A IoannidisThomas A Trikalinos
Jun 19, 2007·Pharmacology & Therapeutics·Mark D Lindner
Mar 5, 2011·Biometrical Journal. Biometrische Zeitschrift·Gerta RückerGuido Schwarzer
Apr 15, 2014·Journal of Clinical Epidemiology·Karen A RobinsonPaul Glasziou
Jan 26, 2013·Journal of Clinical Epidemiology·Anne-Sophie JannotThomas V Perneger
Jun 4, 2015·PloS One·Mark D Lindner, Richard K Nakamura
Jun 13, 2017·Journal of Clinical Epidemiology·Bram DuyxMaurice P Zeegers
Apr 4, 2018·PloS One·Mark D LindnerNasim A Khan
Dec 14, 2011·The Cochrane Database of Systematic Reviews·Ole Jakob StorebøChristian Gluud
Jan 31, 2006·American Journal of Epidemiology·Lise Lotte Gluud
Jun 22, 2019·The Cochrane Database of Systematic Reviews·Ole Jakob StorebøChristian Gluud
Aug 22, 2017·Frontiers in Human Neuroscience·Denes Szucs, John P A Ioannidis
Aug 14, 2020·Science and Engineering Ethics·Miriam J E UrlingsMaurice P A Zeegers
Aug 21, 2007·Science and Engineering Ethics·Lucy Carter
Sep 25, 2020·BMJ : British Medical Journal·Rafael Dal-RéAna Marušić

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.